IPS Partners with AdhereTech to develop the first Internet of Things (IOT) pill bottle
Thousands of patients now using "smart" AdhereTech pill bottle to improve medication adherence.
Intelligent Product Solutions (IPS) partnered with AdhereTech to design and develop a "smart" pill bottle that reminds patients to take their medication. The AdhereTech Internet of Things pill bottle is now being used by thousands of patients, through major healthcare providers and pharmaceutical companies.
To increase medication adherence, the AdhereTech pill bottle can send a text message (to a patient or caregiver), light up, or play a song if patients forget to take their medication. AdhereTech is currently used by many top pharmaceutical companies and hospitals, and these innovative smart bottles improves medication adherence by an average of 20%.
For the design of the second generation AdhereTech "smart" pill bottle, AdhereTech worked with IPS to provide a full range of design services from prototype through manufacturing, including mechanical electrical and industrial design. From its first generation pill bottle to the second generation designed by IPS, the AdhereTech pill bottle needed to be an attractive, user-friendly and manufacturable.
"We selected IPS as our product design partner because of its full range of product design expertise, and in particular, its expertise in designing wireless products — our product essentially a pill bottle with the insides of a cell phone," said Josh Stein, CEO and Cofounder of AdhereTech. "IPS helped us to design and build the second generation product, which works globally and can be manufactured at scale. IPS also helped us improve the look and feel of the device, battery life and durability."
As part of the design process, IPS worked to create a power efficient design with more than 6 months of battery life, as the AdhereTech pill bottle needed to exceed a patient's prescription, without requiring battery recharging. In addition to product design, IPS facilitated preliminary regulatory reviews and shepherded the design through FCC regulatory testing.
"With the AdhereTech pill bottle, we designed a patient-friendly bottle that is packed with dense electronics, while working with such ease that it doesn't require the patient to connect to Internet, plug it in to charge it, or download any software — all of that is done automatically," said Mitch Maiman, President and Cofounder of Intelligent Product Solutions. "Working with AdhereTech was a true partnership, and we are thrilled to work with startups such as AdhereTech to help make their design concepts a success."
According to Stein, AdhereTech will manufacture more than 10,000 of its second generation "smart" pill bottles in 2016.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance